References
- Boiani M, Gonzalez M. Imidazole and benzimidazole derivatives as chemotherapeutic agents. Mini-Rev Med Chem 2005;5:409–24
- Özden S, Atabey D, Yıldız S, Göker H. Synthesis and potent antimicrobial activity of some novel methyl or ethyl 1H-benzimidazole-5-carboxylates derivatives carrying amide or amidine groups. Bioorg Med Chem 2005;13:1587–97
- Göker H, Özden S, Yıldız S, Boykin D. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines. Eur J Med Chem 2005;40:1062–9
- Göker H, Alp M, Yıldız S. Synthesis & potent antimicrobial activity of some novel N-(alkyl)-2-phenyl-1H-benzimidazole-5-carboxamidines. Molecules 2005;10:1377–86
- Hilliard JJ, Goldschmidt RM, Licata L, et al. Multiple mechanisms of action for inhibitors of histidine protein kinases from bacterial two-component systems. Antimicrob Agents Chemother 1999;43:1693–9
- Report on Carcinogens. US Department of Health and Human Services Public Health Service National Toxicology Program, Twelfth Edition 2011. Available from: http://ntp.niehs.nih.gov/go/roc12 http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf [last accessed 13 Mar 2014]
- Miller KJ, Anderholm DC, Ames MM. Metabolic activation of the serotonergic neurotoxin para-chloroamphetamine to chemically reactive intermediates by hepatic and brain microsomal preparations. Biochem Pharmacol 1986;35:1737–42
- Biron KK, Harvey RJ, Chamberlain SC, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrob Agents Chemother 2002;46:2365–72
- Budow S, Kozlowska M, Gorska A, et al. Substituted benzimidazoles: antiviral activity and synthesis of nucleosides. Arkivoc 2009; 2009(iii):225–50
- Chen JJ, Wei Y, Williams JD, et al. Design, synthesis and antiviral evaluation of some polyhalogenated indole C-nucleosides. Nucleos Nucleot Nucl 2005;24:1417–37
- Alp M, Göker H, Brun R, Yıldız S. Synthesis and antiparasitic and antifungal evaluation of 2′-arylsubstituted-1H,1′H-[2,5′]bisbenzimidazolyl-5-carboxamidines. Eur J Med Chem 2009;44:2002–8
- Püsküllü MO, Yıldız S, Göker H. Synthesis and antistaphylococcal activity of N-substituted-1H-benzimidazole-sulphonamides. Arch Pharm Chem Life Sci 2010;343:31–9
- Ates-Alagöz Z, Alp M, Kus C, et al. Synthesis and potent antimicrobial activities of some novel retinoidal monocationic benzimidazoles. Arch Pharm Chem Life Sci 2006;339:74–80
- National Committee for Clinical Laboratory Standards. Methods for dilution: antimicrobial susceptibility tests for bacteria that grow aerobically, 5th edition, 17 (2); approved standard (M7A5). Wayne (PA): National Committee for Clinical Laboratory Standards; 2000
- National Institute of Health. Guidance document on using in vitro data to estimate in vivo starting doses for acute toxicity, NIH Publication No. 01-4500, August 2001
- Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000;43:3714–17
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3–25
- Prasanna S, Doerksen RJ. Topological polar surface area: a useful descriptor in 2D-QSAR. Curr Med Chem 2009;16:21–41